Please Wait
Applying Filters...
menu
    • menu
    Sanofi-PSE
    News
    Hart-Scott-Rodino waiting period expires for Sanofi acqu. of Provention Bio

    26 Apr 2023

    // GLOBENEWSWIRE

    Sanofi's Provention buy hit with FTC delay

    11 Apr 2023

    // Angus Liu FIERCE PHARMA

    Sanofi to acquire Provention Bio for $2.9 billion

    14 Mar 2023

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Provention bio

    Contact Supplier

    Website

    BMWS24

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
    Menu

    Provention Bio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Hart-Scott-Rodino waiting period expires for Sanofi acqu. of Provention Bio
    Hart-Scott-Rodino waiting period expires for Sanofi acqu. of Provention Bio

    26 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/26/2654655/0/en/Press-Release-Hart-Scott-Rodino-waiting-period-expires-for-Sanofi-s-acquisition-of-Provention-Bio-Inc.html

    GLOBENEWSWIRE
    26 Apr 2023
    Share Share
    Sanofi's Provention buy hit with FTC delay
    Sanofi's Provention buy hit with FTC delay

    11 Apr 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/sanofis-29b-deal-provention-bio-hit-protracted-ftc-review-wheres-pfizer-seagen

    Angus Liu FIERCE PHARMA
    11 Apr 2023
    Share Share
    Sanofi to acquire Provention Bio for $2.9 billion
    Sanofi to acquire Provention Bio for $2.9 billion

    14 Mar 2023

    // PRESS RELEASE

    https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367

    PRESS RELEASE
    14 Mar 2023
    Share Share
    Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release
    Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release

    13 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/provention-bio-cancels-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call-301769842.html

    PR NEWSWIRE
    13 Mar 2023
    Share Share
    Provention Bio Announces the Grant of Inducement Awards
    Provention Bio Announces the Grant of Inducement Awards

    03 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/provention-bio-announces-the-grant-of-inducement-awards-301761851.html

    PR NEWSWIRE
    03 Mar 2023
    Share Share
    Provention to Report Fourth Quarter and Full Year 2022 Financial Results
    Provention to Report Fourth Quarter and Full Year 2022 Financial Results

    23 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/provention-bio-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-16-2023-301754445.html

    PR NEWSWIRE
    23 Feb 2023
    Share Share